Over the last 7 days, the United States market has risen by 1.4%, contributing to a 19% increase over the past year, with earnings expected to grow by 19% annually in the coming years. While the term 'penny stock' might seem outdated, it remains relevant as these smaller or newer companies can offer significant opportunities when backed by solid financials. In this article, we'll explore three penny stocks that demonstrate both balance sheet strength and potential for substantial returns, providing investors with a chance to uncover hidden value in quality companies.

Let's take a closer look at a couple of our picks from the screened companies.

Aldeyra Therapeutics (ALDX)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Aldeyra Therapeutics, Inc. is a biotechnology company focused on discovering and developing therapies for immune-mediated diseases, with a market cap of approximately $136.93 million.

Operations: Aldeyra Therapeutics, Inc. does not report any specific revenue segments.

Market Cap: $136.93M

Aldeyra Therapeutics, Inc., with a market cap of approximately US$136.93 million, is pre-revenue and primarily focused on developing therapies for immune-mediated diseases. The company recently experienced significant index exclusions, being dropped from multiple Russell indices as of June 27, 2026. Despite this setback and its unprofitability, Aldeyra has managed to reduce its losses by 7.1% annually over the past five years and maintains a sufficient cash runway for more than a year based on current free cash flow levels. Additionally, Aldeyra's board is seasoned with an average tenure of 11.5 years among directors.

Anavex Life Sciences (AVXL)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Anavex Life Sciences Corp. is a biopharmaceutical company with a market cap of $239.09 million.

Operations: Anavex Life Sciences Corp. currently does not report any revenue segments.

Market Cap: $239.09M

Anavex Life Sciences Corp., with a market cap of US$239.09 million, remains pre-revenue and faces challenges, including recent index exclusions from the S&P Biotechnology Select Industry Index and a delinquency notification from Nasdaq due to delayed SEC filings. However, the company was added to several Russell indices on June 27, 2026. Anavex is debt-free and its short-term assets significantly exceed liabilities, offering financial stability despite unprofitability. The board is experienced with an average tenure of 11.3 years. The company has sufficient cash runway for over three years if current cash flow trends persist without significant revenue streams yet established.

Waterdrop (WDH)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Waterdrop Inc. operates as an online insurance brokerage in the People’s Republic of China, connecting users with insurance products, and has a market cap of approximately $416.79 million.

Operations: The company's revenue is primarily derived from its insurance segment, which generated CN¥4.06 billion, supplemented by CN¥255.23 million from crowdfunding activities.

Market Cap: $416.79M

Waterdrop Inc., with a market cap of CN¥416.79 million, has shown robust revenue generation primarily from its insurance segment, totaling CN¥4.06 billion, alongside crowdfunding activities contributing CN¥255.23 million. The company's financial health is bolstered by short-term assets exceeding both long-term and short-term liabilities, and cash surpassing total debt levels. Despite a slight decline in net profit margins compared to last year, Waterdrop's earnings growth remains strong at 41.5%, outpacing the industry average of 36.2%. Recent board changes include the appointment of Ms. Qianfei Chang as an independent director effective July 1, 2026.

Taking Advantage

• Unlock more gems! Our US Penny Stocks screener has unearthed 317 more companies for you to explore.Click here to unveil our expertly curated list of 320 US Penny Stocks.
• Want To Explore Some Alternatives? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 31 best rare earth metal stocks of the very few that mine this essential strategic resource.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.